Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 67, Issue 2, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/aac.01409-22
Keywords
AmpC; Pseudomonas aeruginosa; antibiotic resistance; beta-lactamase; imipenem
Categories
Ask authors/readers for more resources
Several mutations in Pseudomonas aeruginosa AmpC have led to higher resistance against ceftazidime and ceftolozane, and also make the bacteria evade inhibition by avibactam. Interestingly, these mutations also make the strains more susceptible to carbapenem. The loss of efficacy in hydrolyzing imipenem by the cephalosporin-resistant AmpC enzymes may be attributed to their increased flexibility and dynamics compared to the wild type.
Several Pseudomonas aeruginosa AmpC mutants have emerged that exhibit enhanced activity against ceftazidime and ceftolozane, while also evading inhibition by avibactam. Interestingly, P. aeruginosa strains harboring these AmpC mutations fortuitously exhibit enhanced carbapenem susceptibility. This acquired susceptibility was investigated by comparing the degradation of imipenem by wild-type and cephalosporin-resistant AmpC. We show that cephalosporin-resistant AmpC enzymes lose their efficacy for hydrolyzing imipenem and suggest that this may be due to their increased flexibility and dynamics relative to the wild type. Several Pseudomonas aeruginosa AmpC mutants have emerged that exhibit enhanced activity against ceftazidime and ceftolozane, while also evading inhibition by avibactam. Interestingly, P. aeruginosa strains harboring these AmpC mutations fortuitously exhibit enhanced carbapenem susceptibility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available